Nass Valley Gateway Ltd(NSVGF)
USD --+0.00%
Reward29Low
Risk85High
📊75%Data
Revenue down 90% YoY
NSVGF
+0.0 · +0.00%
USD · PINK
Nass Valley Gateway Ltd | Healthcare
Earnings Deterioration
Market Cap:3.29M
ℹ️
Reward Rating
29
Low
Bottom 1% (model universe)
75% data coverage
ℹ️
Risk Rating
85
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on NSVGF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Nass Valley Gateway Ltd?

sells and distributes hemp-based cannabidiol (CBD) with zero THC cannabinol products.

NSVGF · Verdict

Limited reward · high risk

NSVGF has limited near-term tailwinds — balance sheet and cash flow weigh on the model output.

Based on 88% data coverage

NSVGF · Verdict

What’s working & what to watch

Watchouts 5

  • Balance sheet6/100

    Current ratio 0.00

  • Cash flow6/100

    -4608% free-cash-flow margin

  • Profitability9/100

    -152284% net margin · 0% ROE

  • Growth15/100

    Rev -57.5% CAGR · earnings -16.1%

  • Volatility35/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Nass Valley Gateway Ltd?

sells and distributes hemp-based cannabidiol (CBD) with zero THC cannabinol products. The company is based in Vancouver, Canada. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 3.29M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Low (29)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap3.29M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.01
52 Week Low0.01
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding329M
No. of EmployeesN/A
IndustryMedical Distribution
ExchangePINK
Beta1.445
CurrencyUSD · Reports in CAD